DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market
DarioHealth Corp. (DRIO)
NASDAQ:AMEX Investor Relations:
dariohealth.com/our-story
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)--Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The company’s latest move expands its GLP-1 offering with prescribing capabilities, positioning Dario to capture a larger share of this lucrative space as demand for medical weight-loss solutions skyrockets across employers and consumers. Following the announcement, Dario’s shares surged nearly 14%, reflecting investor excitement over this significant growth opportunity.The market for GLP-1 medications, driven by blockbuster drugs like Novo Nordisk’s Ozempic and Wegovy, is transforming how obesity and weight management
Read more
Impact Snapshot
Event Time:
DRIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DRIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DRIO alerts
High impacting DarioHealth Corp. news events
Weekly update
A roundup of the hottest topics
DRIO
News
- PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health TransformationBusiness Wire
- DarioHealth Corp. (NASDAQ: DRIO) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $1.00 price target on the stock, down previously from $2.00.MarketBeat
- DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025 [Yahoo! Finance]Yahoo! Finance
- DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025PR Newswire
- DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets [Yahoo! Finance]Yahoo! Finance
DRIO
Earnings
- 11/7/24 - Beat
DRIO
Sec Filings
- 1/22/25 - Form 8-K
- 1/17/25 - Form D
- 1/17/25 - Form D
- DRIO's page on the SEC website